化学名称: 2-((2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-2-ium
微笑: C[N+]1([C@]([C@@H]([C@H]2O)O)([H])O[C@@H]([C@H]2O)C(O)=O)CC3N(CC1)C4=NC=CC=C4CC5=CC=CC=C35
印地语: InChI=1/C8H14O2/c1-3-5-7(6-4-2)8(9)10/h3,7H,1,4-6H2,2H3,(H,9,10)
Determination of mirtazapine in spiked human plasma and tablets by first derivative spectrofluorimetric method
Rasha M.Youssef
Saudi Pharmaceutical Journal Volume 18, Issue 1, January 2010, Pages 45-49
Development and Validation of a Reversed-Phase HPLC Method for Separation and Simultaneous Determination of Process-Related Substances of Mirtazapine in Bulk Drugs and Formulations
R. Nageswara Rao* and A. Narasa Raju
Journal of Chromatographic Science, Vol. 47, March 2009; 223-230
Simultaneous Determination of Mirtazapine and its Three Main Impurities by a High Performance Thin Layer Chromatography/ Densitometry Method
T. Sheshashena Reddy and P. Sita Devi
Journal of Liquid Chromatography & Related Technologiesw, 31: 1204–1212, 2008